Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
24 Cards in this Set
- Front
- Back
Isoniazid
MOA |
Bacterstatic
MOA: inhibits of the biosynthesis of mycolic acids. |
|
Resistance of Isoniazid
|
missense mutation inhA
|
|
Drug - Isoniazid
|
- Antacids interfere with absorption.
- exreted in urine |
|
Adverse Effects of INH.
|
- Peripheal Neuropathy
- GI - Increased liver enzymes - Hepatitis |
|
Rifampin act on what bugs:
BACTERICIDAL AGENT |
- M. Bovis
- M. kansasii - M. Tuberculosis - S. mediterranei |
|
Rifampin MOA:
|
- inhibits DNA - dependent RNA polymerase.
|
|
Resistance MOA for RIFAMPIN
|
- Mutations of the polymerase rpoB gene.
|
|
Excretion of the INH:
|
- BILE
- METABOLITE are active. |
|
Adverse Effects of Rifampin
|
- Orange color sweat, etc.
- Flu-like syndrome - induces drug metabolizm - elevated liver enzymes |
|
Organisms covered by rifabutin:
|
- MAC prophylaxis
- M. tuberculosis. |
|
RIFAPENTINE: CI,
USED FOR OSE: |
A.E: PORPHYRIA
dOSE: ONCE WEEKLY lONG ACTING AGENT IN TB. |
|
Ethambutol: bugs
|
M. tuberculosis
M. avium BACTERIOSTATIC. |
|
Ethambutol:
MOA: RESISTANCE: |
- Inhibits arabinosyl transferase.
- Resistance: signle a.a. changes in embA gene. |
|
Excreted unchanged in the urine:
|
- glomerular filtration and tubular secretion
- excreted in the urine. |
|
Pyrazinamide MOA:
|
- MOA: Target mycobacterial fatty acid synthase I gene in volved in mycolic acid biosynthsis.
|
|
Pyrazinamide excreted by:
|
glomerular filtration
|
|
A.E. OF pyrazinamide:
|
1. Liver toxicity
2. Hyperuricemia 3. GI distress 4. Arthralgia |
|
Ethionamide MOA:
|
- mycolic acid synthesis inhibitor
- resistance when used alone - excreted in the bile |
|
Ethionamide ADVERSE EFFECTS:
|
Hypothroidism, glycemia, hepatitis
N/V Anorexia, abdominal pain Metallic taste |
|
Aminosalicyclic Acid:
|
M. Tuberculosis
GI: - Anorexia, Nausea, Abdominal Distress - Diarrhea, Epigastric Pain. |
|
Cycloserine: MOA
|
- Cell wall inhibitor
- inhibits alanine racemase - ihhibits D-alanyl-D-alanine ligase. |
|
Excretion of cycloserine:
|
- kidney, accumulates renal dysfunction
|
|
Capreomycin:
|
Polypeptide antibiotic
- excreted unchanged in the urine. |
|
A.E. of Capreomycin:
|
1. Nephrotoxicity
2. Ototoxicity 3. Vestibular Toxicity 4. Partial NM Blockade. |